166 related articles for article (PubMed ID: 31729088)
21. Immunoscore Signature Predicts Postoperative Survival and Adjuvant Chemotherapeutic Benefits in Esophageal Squamous Cell Carcinoma.
Zhuge L; Huang B; Xie J; Gao Z; Zheng D; Zheng S; Xiang J; Zhang J
Cancer Manag Res; 2020; 12():12885-12894. PubMed ID: 33364836
[TBL] [Abstract][Full Text] [Related]
22. [Prognostic analysis of T1 and T2 stage gallbladder cancer with invasion within the gallbladder wall].
Hou CS; Xu Z; Zhang TL; Peng Y; Ling XF; Wang LX; Zhou XS
Zhonghua Wai Ke Za Zhi; 2006 Dec; 44(23):1620-3. PubMed ID: 17359693
[TBL] [Abstract][Full Text] [Related]
23. High CD8
Fluxá P; Rojas-Sepúlveda D; Gleisner MA; Tittarelli A; Villegas P; Tapia L; Rivera MT; López MN; Catán F; Uribe M; Salazar-Onfray F
BMC Cancer; 2018 Mar; 18(1):243. PubMed ID: 29499656
[TBL] [Abstract][Full Text] [Related]
24. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
[TBL] [Abstract][Full Text] [Related]
25. The clinical significance and underlying correlation of pStat-3 and integrin αvβ6 expression in gallbladder cancer.
Enyu L; Na W; Chuanzong Z; Ben W; Xiaojuan W; Yan W; Zequn L; Jianguo H; Jiayong W; Benjia L; Cheng P; Min Z; Zongli Z
Oncotarget; 2017 Mar; 8(12):19467-19477. PubMed ID: 28061445
[TBL] [Abstract][Full Text] [Related]
26. ImmunoScore Signature: A Prognostic and Predictive Tool in Gastric Cancer.
Jiang Y; Zhang Q; Hu Y; Li T; Yu J; Zhao L; Ye G; Deng H; Mou T; Cai S; Zhou Z; Liu H; Chen G; Li G; Qi X
Ann Surg; 2018 Mar; 267(3):504-513. PubMed ID: 28002059
[TBL] [Abstract][Full Text] [Related]
27. Surgical procedure determination based on tumor-node-metastasis staging of gallbladder cancer.
He XD; Li JJ; Liu W; Qu Q; Hong T; Xu XQ; Li BL; Wang Y; Zhao HT
World J Gastroenterol; 2015 Apr; 21(15):4620-6. PubMed ID: 25914471
[TBL] [Abstract][Full Text] [Related]
28. Tumor Immune Microenvironment and Chemosensitivity Signature for Predicting Response to Chemotherapy in Gastric Cancer.
Jiang Y; Xie J; Huang W; Chen H; Xi S; Han Z; Huang L; Lin T; Zhao LY; Hu YF; Yu J; Cai SR; Li T; Li G
Cancer Immunol Res; 2019 Dec; 7(12):2065-2073. PubMed ID: 31615816
[TBL] [Abstract][Full Text] [Related]
29. Tumour-Infiltrating Immune Cell-Based Subtyping and Signature Gene Analysis in Breast Cancer Based on Gene Expression Profiles.
Jiang J; Pan W; Xu Y; Ni C; Xue D; Chen Z; Chen W; Huang J
J Cancer; 2020; 11(6):1568-1583. PubMed ID: 32047563
[TBL] [Abstract][Full Text] [Related]
30. Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic response.
Qi Y; Chang Y; Wang Z; Chen L; Kong Y; Zhang P; Liu Z; Zhou Q; Chen Y; Wang J; Bai Q; Xia Y; Liu L; Zhu Y; Xu L; Dai B; Guo J; Wang Y; Xu J; Zhang W
Cancer Immunol Immunother; 2019 Dec; 68(12):2067-2080. PubMed ID: 31720813
[TBL] [Abstract][Full Text] [Related]
31. [Clinical value of superior mesenteric vein (No.14v) lymph node dissection in D2 gastrectomy for locally advanced distal gastric cancer].
Lu W; Zeng X; Li N; Liu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1136-1141. PubMed ID: 30370512
[TBL] [Abstract][Full Text] [Related]
32. The role of neoadjuvant chemotherapy or chemoradiotherapy for advanced gallbladder cancer - A systematic review.
Hakeem AR; Papoulas M; Menon KV
Eur J Surg Oncol; 2019 Feb; 45(2):83-91. PubMed ID: 30287098
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of combined preoperative fibrinogen and CA199 in gallbladder cancer patients.
Xu WY; Zhang HH; Yang XB; Bai Y; Lin JZ; Long JY; Xiong JP; Zhang JW; Sang XT; Zhao HT
World J Gastroenterol; 2018 Apr; 24(13):1451-1463. PubMed ID: 29632426
[TBL] [Abstract][Full Text] [Related]
34. Association of Wnt signaling pathway genetic variants in gallbladder cancer susceptibility and survival.
Yadav A; Gupta A; Yadav S; Rastogi N; Agrawal S; Kumar A; Kumar V; Misra S; Mittal B
Tumour Biol; 2016 Jun; 37(6):8083-95. PubMed ID: 26715268
[TBL] [Abstract][Full Text] [Related]
35. Individualized nomogram improves diagnostic accuracy of stage I-II gallbladder cancer in chronic cholecystitis patients with gallbladder wall thickening.
Zhou D; Wang JD; Yang Y; Yu WL; Zhang YJ; Quan ZW
Hepatobiliary Pancreat Dis Int; 2016 Apr; 15(2):180-8. PubMed ID: 27020635
[TBL] [Abstract][Full Text] [Related]
36. Validation of American Joint Committee on Cancer eighth staging system for gallbladder cancer and its lymphadenectomy guidelines.
Lee AJ; Chiang YJ; Lee JE; Conrad C; Chun YS; Aloia TA; Vauthey JN; Tzeng CD
J Surg Res; 2018 Oct; 230():148-154. PubMed ID: 30100032
[TBL] [Abstract][Full Text] [Related]
37. [Analysis of treatment modalities and prognosis of patients with gallbladder cancer in China from 2010 to 2017].
Ren T; Li YS; Geng YJ; Li ML; Wu XS; Wu WW; Wang XA; Shu YJ; Bao RF; Dong P; Gong W; Gu J; Wang XF; Lu JH; Mu JS; Pan WH; Zhang X; Zhang XL; Fei ZW; Zhang ZY; Wang Y; Cao H; Sun B; Cui YF; Zhu CF; Li B; Zheng LH; Qian YB; Liu J; Dang XY; Liu C; Peng SY; Quan ZW; Liu YB
Zhonghua Wai Ke Za Zhi; 2020 Sep; 58(9):697-706. PubMed ID: 32878417
[No Abstract] [Full Text] [Related]
38. Loss of MTUS1 Expression Is Associated With Poor Prognosis in Patients With Gallbladder Carcinoma.
Sim J; Kim Y; Kim H; Bang S; Jee S; Park S; Shin SJ; Jang K
In Vivo; 2020; 34(1):125-132. PubMed ID: 31882471
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Laparoscopic and Open Approach in Treating Gallbladder Cancer.
Feng JW; Yang XH; Liu CW; Wu BQ; Sun DL; Chen XM; Jiang Y; Qu Z
J Surg Res; 2019 Feb; 234():269-276. PubMed ID: 30527484
[TBL] [Abstract][Full Text] [Related]
40. Model Based on Alkaline Phosphatase and Gamma-Glutamyltransferase for Gallbladder Cancer Prognosis.
Xu XS; Miao RC; Zhang LQ; Wang RT; Qu K; Pang Q; Liu C
Asian Pac J Cancer Prev; 2015; 16(15):6255-9. PubMed ID: 26434825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
